Edward Nash
Stock Analyst at Canaccord Genuity
(4.94)
# 162
Out of 4,683 analysts
402
Total ratings
55.9%
Success rate
32.6%
Average return
Main Sectors:
Stocks Rated by Edward Nash
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $6 → $7 | $2.33 | +200.43% | 4 | Aug 26, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $153 | $73.77 | +107.40% | 3 | Aug 17, 2026 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Reiterated: Buy | $11.08 → $13.85 | $2.97 | +366.44% | 26 | Aug 17, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $5 | $0.8414 | +494.25% | 20 | Aug 17, 2026 | |
| CORT Corcept Therapeutics | Reiterated: Buy | $161 | $119.80 | +34.39% | 56 | Aug 13, 2026 | |
| PLRX Pliant Therapeutics | Reiterated: Hold | $3 | $1.16 | +158.62% | 16 | Aug 13, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Reiterated: Buy | $98 | $78.68 | +24.56% | 5 | Aug 12, 2026 | |
| MDGL Madrigal Pharmaceuticals | Reiterated: Buy | $587 → $612 | $538.88 | +13.57% | 42 | Aug 11, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $70 | $67.12 | +4.29% | 41 | Aug 11, 2026 | |
| APGE Apogee Therapeutics | Reiterated: Hold | $135 | $134.95 | +0.12% | 16 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $49 → $56 | $10.86 | +415.65% | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 → $111 | $49.35 | +124.92% | 3 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $40.57 | +47.89% | 13 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $125.55 | +2.75% | 5 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $114 | $34.38 | +231.59% | 9 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 | $2.80 | +792.86% | 3 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $4.82 | +314.94% | 14 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $5.04 | n/a | 8 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $5.34 | n/a | 6 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $15 | $4.33 | n/a | 15 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $1 | $0.0001 | n/a | 2 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $7.67 | n/a | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 | $2.42 | n/a | 1 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $39 | $5.23 | n/a | 9 | May 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $176 | $19.46 | n/a | 15 | Feb 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 → $64 | $50.95 | n/a | 2 | Feb 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $126 → $117 | $65.61 | n/a | 14 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $71 | $26.44 | n/a | 11 | Jan 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $156 | $58.00 | n/a | 1 | Sep 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $132 | $1,047.10 | n/a | 1 | Sep 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $22 → $4 | $14.23 | n/a | 3 | Jun 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $18.53 | n/a | 1 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $23 | $6.01 | n/a | 2 | May 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $0.0001 | n/a | 1 | Sep 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 → $2 | $0.0001 | n/a | 2 | May 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $6 | $4.17 | n/a | 8 | May 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $16.49 | n/a | 3 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $11 | $4.29 | n/a | 3 | Sep 4, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $0.1505 | n/a | 1 | Jun 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $16.40 | n/a | 2 | May 3, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $29.58 | n/a | 1 | Jan 28, 2013 |
Connect Biopharma Holdings
Aug 26, 2026
Reiterated: Buy
Price Target: $6 → $7
Current: $2.33
Upside: +200.43%
Nektar Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $153
Current: $73.77
Upside: +107.40%
Cardiol Therapeutics Inc.
Aug 17, 2026
Reiterated: Buy
Price Target: $11.08 → $13.85
Current: $2.97
Upside: +366.44%
Rani Therapeutics Holdings
Aug 17, 2026
Reiterated: Buy
Price Target: $5
Current: $0.8414
Upside: +494.25%
Corcept Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $161
Current: $119.80
Upside: +34.39%
Pliant Therapeutics
Aug 13, 2026
Reiterated: Hold
Price Target: $3
Current: $1.16
Upside: +158.62%
Kiniksa Pharmaceuticals International,
Aug 12, 2026
Reiterated: Buy
Price Target: $98
Current: $78.68
Upside: +24.56%
Madrigal Pharmaceuticals
Aug 11, 2026
Reiterated: Buy
Price Target: $587 → $612
Current: $538.88
Upside: +13.57%
Travere Therapeutics
Aug 11, 2026
Maintained: Buy
Price Target: $70
Current: $67.12
Upside: +4.29%
Apogee Therapeutics
Aug 11, 2026
Reiterated: Hold
Price Target: $135
Current: $134.95
Upside: +0.12%
Aug 11, 2026
Maintained: Buy
Price Target: $49 → $56
Current: $10.86
Upside: +415.65%
Aug 7, 2026
Maintained: Buy
Price Target: $101 → $111
Current: $49.35
Upside: +124.92%
Aug 6, 2026
Maintained: Buy
Price Target: $60
Current: $40.57
Upside: +47.89%
Aug 6, 2026
Reiterated: Buy
Price Target: $129
Current: $125.55
Upside: +2.75%
Jul 30, 2026
Reiterated: Buy
Price Target: $107 → $114
Current: $34.38
Upside: +231.59%
May 14, 2026
Rated: Buy
Price Target: $25
Current: $2.80
Upside: +792.86%
Apr 2, 2026
Maintained: Buy
Price Target: $20
Current: $4.82
Upside: +314.94%
Oct 2, 2024
Maintained: Buy
Price Target: $9
Current: $5.04
Upside: n/a
May 17, 2023
Maintained: Hold
Price Target: $2
Current: $5.34
Upside: n/a
Aug 8, 2022
Downgraded: Hold
Price Target: $5 → $15
Current: $4.33
Upside: n/a
Jul 29, 2022
Downgraded: Hold
Price Target: $12 → $1
Current: $0.0001
Upside: n/a
May 18, 2021
Maintained: Buy
Price Target: $25
Current: $7.67
Upside: n/a
Jun 5, 2019
Downgraded: Hold
Price Target: $5
Current: $2.42
Upside: n/a
May 20, 2019
Maintained: Buy
Price Target: $60 → $39
Current: $5.23
Upside: n/a
Feb 27, 2019
Reiterated: Buy
Price Target: $176
Current: $19.46
Upside: n/a
Feb 26, 2019
Maintained: Buy
Price Target: $48 → $64
Current: $50.95
Upside: n/a
Feb 25, 2019
Maintained: Buy
Price Target: $126 → $117
Current: $65.61
Upside: n/a
Jan 23, 2019
Maintained: Buy
Price Target: $54 → $71
Current: $26.44
Upside: n/a
Sep 24, 2018
Maintained: Buy
Price Target: $156
Current: $58.00
Upside: n/a
Sep 17, 2018
Maintained: Buy
Price Target: $132
Current: $1,047.10
Upside: n/a
Jun 27, 2018
Downgraded: Hold
Price Target: $22 → $4
Current: $14.23
Upside: n/a
Jun 25, 2018
Initiated Coverage: Buy
Price Target: $26
Current: $18.53
Upside: n/a
May 16, 2018
Maintained: Buy
Price Target: $26 → $23
Current: $6.01
Upside: n/a
Sep 18, 2017
Maintained: Buy
Price Target: $24
Current: $0.0001
Upside: n/a
May 16, 2017
Reiterated: Hold
Price Target: $1 → $2
Current: $0.0001
Upside: n/a
May 5, 2017
Reiterated: Hold
Price Target: $3 → $6
Current: $4.17
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $9
Current: $16.49
Upside: n/a
Sep 4, 2014
Downgraded: Hold
Price Target: $14 → $11
Current: $4.29
Upside: n/a
Jun 17, 2013
Initiated Coverage: Buy
Price Target: n/a
Current: $0.1505
Upside: n/a
May 3, 2013
Downgraded: Sell
Price Target: n/a
Current: $16.40
Upside: n/a
Jan 28, 2013
Initiated Coverage: Buy
Price Target: n/a
Current: $29.58
Upside: n/a